MCCP
GSK icon

Mission Creek Capital Partners’s GSK GSK Stock Holding History

Mission Creek Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,024
Closed -$236K – 169
2019
Q4 		$236K Buy
+4,024
New +$224K 0.11% 176

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Mission Creek Capital Partners's GSK Position: Q1 2020 in Review

Mission Creek Capital Partners sold out of GSK (GSK) in Q1 2020, closing a stake of 4,024 shares — an estimated $236K sold.

Mission Creek Capital Partners first reported a position in GSK in Q4 2019 and held it in 1 quarter. The position peaked at $236K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Mission Creek Capital Partners reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Mission Creek Capital Partners sold 4,024 GSK shares in Q1 2020, an estimated $236K.
  • Mission Creek Capital Partners first reported a position in GSK in Q4 2019 and held it in 1 quarter.
  • Mission Creek Capital Partners's GSK position peaked at $236K in Q4 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Mission Creek Capital Partners's 13F filing for Q1 2020, filed 14 May 2020.